Hypersensitivity & Allergy Flashcards
(42 cards)
• Explain Appropriate Immune Tolerance
Can occur to SELF & FOREIGN harmless proteins - involves:
• antigen recognition
• generation of T-reg cells
• regulatory (blocking) Ab production (IgG4)
Antigen recognition in absence of “danger” = immune tolerance
Broadly, give the classifications of Hypersensitivity Reactions
Classified by Gell & Coomb:
o Type 1
• Immediate Hypersensitivity (allergic)
o Type 2
• Ab-dependent Cytotoxicity
o Type 3
• Immune Complez Mediated
o Type 4
• Delayed Cell Mediated
Explain against what are hypersensitivity reactions responding to?
Hypersensitivity reactions occurs when responses are mounted against:
Harmless foreign antigens
• e.g. pollen
Auto-antigens
• e.g. Auto-immune
Allo-antigens
• e.g. transfusion reactions
Allo-antigens are antigens present in only SOME individuals (i.e. ABO blood groups).
Note – many diseases involve a mixture of the different types of hypersensitivity reactions
What is Type 1 hypersensitivity mediated by and examples?
Mediated by:
IgE
Example: • Anaphylaxis • Asthma • Rhinitis • Food Allergy
Explain how Type 1 hypersensitivity comes about
1st exposure:
• SENSITISATION rather than tolerance
• IgE AB production = binds to mast cells and basophils
2nd exposure:
• MORE IgE produced
• antigens crosslink IgE on mast cells and basophils = degranulation = release of inflammatory mediators
What is Type II hypersensitivity mediated by and what does clinical presentation depend on?
Mediated by:
• Abs responding to cell-surface OR matrix-bound antigen (INSOLUBLE)
Clinical Presentation depends on TARGET TISSUE
Give examples of Clinical presentations in Type II Hypersensitivity
Organ-specific AI diseases - reactions associated with Abs directed against:
- Anti-ACh R AB –> Myasthenia gravis
- Anti-glomerular basement membrane AB –> Glomerulonephritis
- Anti-epithelial cell cement protein AB –> Pemphigus vulgaris
- Intrinsic factor blocking AB –> Pernicious anaemia
AI cytopaenias – AB-mediated blood cell destruction:
- Haemolytic anaemia.
- Thrombocytopaenia.
- Neutropenia
What tests can you carry out for Type II Hypersensitivity to test for specific Abs?
(1) Immunofluorescence
(2) ELISA
• e.g. anti-CCP (Cyclic-Citrullinated Peptide) Abs for RA
What is Type III hypersensitivity mediated by and what does this result in?
Mediated by:
• antigen-Ab complexes
Abs respond to SOLUBLE antigens
• these can NOT traverse vessel walls very easily
SO
• are DEPOSITED in various TISSUES
Explain what the deposition of the antigen-Ab complexes in the various tissues leads to in Type III Hypersensitivity
Leads to:
• complement activation
&
• cell recruitment
Leads to activation of cascades such as clotting & leads to tissue damage:
• e.g. SLE
• e.g. Vasculitis (in kidneys, skin, joints, lungs)
What is Type IV hypersensitivity mediated by and examples?
Mediated:
• T-cells
Examples: • Chronic GRAFT rejection • Chronic graft rejection • Graft-versus-Host disease (GVHD) • Coeliac disease • Contact hypersensitivity • Allergic inflammation – asthma, rhinitis, eczema
Explain the mechanisms of Type IV Hypersensitivity Responses
Three main Varieties:
• Th1 - produces lots of GAMMA-IFN (activates macrophages - producing TNF-a which causes tissue damage)
- Cytotoxic
- Th2 - releases IL-4/5/13 (allergic inflammation)
Mechanisms:
• transient or persistent antigen presence = T-cell activation of macrophages & CTLs = TNF-a damage
Nickel and hypersensitivity?
Nickel can cause a Type IV Hypersensitivity
• CONTACT HYPERSENSITIVITY
What causes inflammation?
CYTOKINES released by the immune cells leads to features of inflammation
Cytokines which INCREASE PERMEABILITY include:
• C3a, C5a
• histamine
• leukotrienes
Other cytokines involved:
• IL-1/2/6
• TNF
• IFN-gamma
Also brought about by CHEMOKINES which mediate cell-trafficking:
• neutrophils, macrophages, lymphocytes & mast cells undego chemotaxis & active cells
• IL-8
• IP-10
Define Atopy
Form of Allergy
Hereditary/constitutional tendency to develop hypersensitivity reactions
• e.g. hay fever, allergic asthma, atopic eczema
Severity varies:
• Mild - occasional symptoms
• Severe - chronic asthma
• Life threatening - anaphylaxis
What are the broad Risk Factors for Allergies?
(1) Genetic
(2) Envrionmental
Explain the Genetic Risk Factor for Allergies
Genetic – 80% of atopies have a family history:
• Polygenic
50-100 genes are associated with asthma and atopy
IL-4 gene cluster – Chr5
• linked to raised IgE, asthma and atopy.
Chr11q IgE Receptor
• genes linked to atopy and asthma.
Genes linked to eczema (filaggrin) and asthma (IL-33, ORMDL3).
Explain the Envrionmental Risk Factor for Allergies
Age
• increases in infancy to a peak in teens and then drops into adulthood.
Gender
• more common in males (childhood) and females (adulthood).
Family size
• more common in small families.
Infections
• lends to early life protection from infections
Animals
• early exposure protects against them
Diet
• breast feeding, anti-oxidants and fatty acids protects against atopy.
What are some types of inflammation in allergy and the associated hypersensitivity reaction?
T1-hypersensitivity (IgE-mediated):
• Anaphylaxis
• Urticaria
• Angioedema
T2-hypersensitivity (IgG-mediated):
• Idiopathic/chronic urticaria
Mixed T1 (IgE), T4 (chronic inflammation) hypersensitivity:
• Asthma
• Rhinitis
• Eczema
What does Expression of Disease require?
Requires:
• development of sensitisation to allergens INSTEAD of tolerance (1o response - usually in early life)
• further allergen exposure to produce disease (memory response - any time after sensitisation)
Explain the Expression of Disease in Atopic Airway Diseases - FIRST STEP?
SENSITISATION!
APC presents the allergen to the naïve T-cell which then becomes: • Th1 cell (produce IFN-g). • Th2 cell (lead to activation of B-cells). • Treg cells (if presented with a harmless antigen).
Explain the Expression of Disease in Atopic Airway Diseases - SECOND STEP?
SUBSEQUENT EXPOSURE!
APC presents the allergen to the Th2 memory cells which leads to: • Degranulation of eosinophils via IL-5. • Production of IgE plasma cells via IL-4, IL-13.
IgE then mobile onto the surface of mast cells and degranulate the mast cells.
• mediators released inc. histamine, cytokines, leukotrienes, PGs
Main Allergic Cell Mediators?
Eosinophils
Neutrophils
Mast Cells
Explain Eosinophils as Allergic Cell Mediators
o 2-5% of blood leukocytes.
o Present in the blood but most are in the tissue
o Recruited during allergic inflammation.
o Generated from bone marrow.
o Have polymorphic nuclei – bi-lobed.
o Have large granules full of toxic proteins.